Rock Springs Capital Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Rock Springs Capital Management’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-165,300	Closed	-$213K	–	167
2017 Q4	$213K	Hold	165,300	–	–	0.01%	144
2017 Q3	$350K	Hold	165,300	–	–	0.02%	145
2017 Q2	$479K	Hold	165,300	–	–	0.02%	144
2017 Q1	$569K	Hold	165,300	–	–	0.03%	137
2016 Q4	$288K	Hold	165,300	–	–	0.02%	132
2016 Q3	$549K	Hold	165,300	–	–	0.03%	135
2016 Q2	$711K	Hold	165,300	–	–	0.05%	135
2016 Q1	$930K	Buy	165,300 +300	+0.2%	+$3.9K	0.08%	122
2015 Q4	$2.84M	Hold	165,000	–	–	0.22%	103
2015 Q3	$3.48M	Buy	165,000 +10,000	+6%	+$343K	0.28%	101
2015 Q2	$7.67M	Hold	155,000	–	–	0.56%	66
2015 Q1	$12.1M	Sell	155,000 -13,500	-8%	-$837K	1.14%	28
2014 Q4	$10.2M	Buy	168,500 +43,500	+35%	+$2.18M	1.19%	25
2014 Q3	$5.33M	Buy	125,000 +34,500	+38%	+$1.85M	0.82%	38
2014 Q2	$5.59M	Buy	90,500 +7,500	+9%	+$436K	1%	32
2014 Q1	$5.39M	Buy	83,000 +30,500	+58%	+$2.06M	1.24%	25
2013 Q4	$2.96M	Buy	+52,500	New	+$2.95M	1.06%	27

Other funds holding OREX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rock Springs Capital Management's OREX Position: Q1 2018 in Review

Rock Springs Capital Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2018, closing a stake of 165,300 shares — an estimated $213K sold.

Rock Springs Capital Management first reported a position in OREX in Q4 2013 and held it in 17 quarters. The position peaked at $12.1M in Q1 2015. 27 funds tracked by Wall St. Rank hold OREX as of Q1 2018.

Rock Springs Capital Management reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Rock Springs Capital Management sold 165,300 Orexigen Therapeutics, Inc. shares in Q1 2018, an estimated $213K.
Rock Springs Capital Management first reported a position in Orexigen Therapeutics, Inc. in Q4 2013 and held it in 17 quarters.
Rock Springs Capital Management's Orexigen Therapeutics, Inc. position peaked at $12.1M in Q1 2015.
27 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2018.

Based on Rock Springs Capital Management's 13F filing for Q1 2018, filed 15 May 2018.